AI English summary of an SEC filing — figures as filed

The company said revenue for Q1 2025 (ended March 29, 2025) was $10.36 billion, about flat from $10.34 billion in the year-ago quarter, and organic revenue growth was 1%.

8-KResults of Operations and Financial ConditionFiled Apr 23, 2025Period of report Apr 23, 2025Summary published (UTC) Oct 8, 2026

Key points

AI summary

The company said revenue for Q1 2025 (ended March 29, 2025) was $10.36 billion, about flat from $10.34 billion in the year-ago quarter, and organic revenue growth was 1%.
Thermo Fisher said GAAP diluted EPS for Q1 was $3.98, up 15% from $3.46 a year earlier, and adjusted EPS was $5.15, up 1% from $5.11 a year earlier.
The company said GAAP operating income for Q1 was $1.72 billion (operating margin of 16.6%) and adjusted operating income was $2.27 billion (adjusted operating margin of 21.9%), compared with 16.1% and 22.0%, respectively, a year earlier.
Thermo Fisher Scientific disclosed that net cash provided by operating activities for Q1 was $723 million, down from $1,251 million a year earlier, and free cash flow was $373 million, compared with $908 million a year earlier. It also said it made share repurchases of $2.0 billion and dividend payments of $149 million.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Q1 Revenue $10.36 billion, Organic Growth 1%

The company said revenue for Q1 2025 (ended March 29, 2025) was $10.36 billion, about flat from $10.34 billion in the year-ago quarter, and organic revenue growth was 1%.

Source · Based on the filing body and exhibits

GAAP Diluted EPS $3.98, Adjusted EPS $5.15

Thermo Fisher said GAAP diluted EPS for Q1 was $3.98, up 15% from $3.46 a year earlier, and adjusted EPS was $5.15, up 1% from $5.11 a year earlier.

Source · Based on the filing body and exhibits

Operating Margin GAAP 16.6%, Adjusted 21.9%

The company said GAAP operating income for Q1 was $1.72 billion (operating margin of 16.6%) and adjusted operating income was $2.27 billion (adjusted operating margin of 21.9%), compared with 16.1% and 22.0%, respectively, a year earlier.

Source · Based on the filing body and exhibits

Operating Cash Flow $723 million, Free Cash Flow $373 million

Thermo Fisher Scientific disclosed that net cash provided by operating activities for Q1 was $723 million, down from $1,251 million a year earlier, and free cash flow was $373 million, compared with $908 million a year earlier. It also said it made share repurchases of $2.0 billion and dividend payments of $149 million.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.